183 related articles for article (PubMed ID: 27215387)
1. Poly(rC)-Binding Protein 2 Regulates Hippo Signaling To Control Growth in Breast Epithelial Cells.
Li F; Bullough KZ; Vashisht AA; Wohlschlegel JA; Philpott CC
Mol Cell Biol; 2016 Aug; 36(16):2121-31. PubMed ID: 27215387
[TBL] [Abstract][Full Text] [Related]
2. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of Hippo signaling pathway in regulating osteoclast formation.
Yang W; Han W; Qin A; Wang Z; Xu J; Qian Y
J Cell Physiol; 2018 Jun; 233(6):4606-4617. PubMed ID: 29219182
[TBL] [Abstract][Full Text] [Related]
4. H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization.
Rawat SJ; Araiza-Olivera D; Arias-Romero LE; Villamar-Cruz O; Prudnikova TY; Roder H; Chernoff J
Curr Biol; 2016 Jun; 26(12):1556-1563. PubMed ID: 27238285
[TBL] [Abstract][Full Text] [Related]
5. The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment.
Skibinski A; Breindel JL; Prat A; Galván P; Smith E; Rolfs A; Gupta PB; LaBaer J; Kuperwasser C
Cell Rep; 2014 Mar; 6(6):1059-1072. PubMed ID: 24613358
[TBL] [Abstract][Full Text] [Related]
6. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
[TBL] [Abstract][Full Text] [Related]
7. Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration.
Mi W; Lin Q; Childress C; Sudol M; Robishaw J; Berlot CH; Shabahang M; Yang W
Oncogene; 2015 Jun; 34(24):3095-106. PubMed ID: 25109332
[TBL] [Abstract][Full Text] [Related]
8. YAP and TAZ Take Center Stage in Cancer.
Zhang K; Qi HX; Hu ZM; Chang YN; Shi ZM; Han XH; Han YW; Zhang RX; Zhang Z; Chen T; Hong W
Biochemistry; 2015 Nov; 54(43):6555-66. PubMed ID: 26465056
[TBL] [Abstract][Full Text] [Related]
9. Structural and Biochemical Analyses of the Core Components of the Hippo Pathway.
Ni L; Luo X
Methods Mol Biol; 2019; 1893():239-256. PubMed ID: 30565138
[TBL] [Abstract][Full Text] [Related]
10. Prolactin promotes crop epithelial proliferation of domestic pigeons (Columba livia) through the Hippo signaling pathway.
Zhu J; Teng X; Wang L; Zheng M; Meng Y; Liu T; Liu Y; Huan H; Gong D; Xie P
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37721785
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive evaluation of Hippo pathway silencing in sarcomas.
Merritt NM; Fullenkamp CA; Hall SL; Qian Q; Desai C; Thomason J; Lambertz AM; Dupuy AJ; Darbro B; Tanas MR
Oncotarget; 2018 Aug; 9(60):31620-31636. PubMed ID: 30167083
[TBL] [Abstract][Full Text] [Related]
12. POPX2 is a novel LATS phosphatase that regulates the Hippo pathway.
Rahmat MB; Zhang S; Koh CG
Oncotarget; 2019 Feb; 10(15):1525-1538. PubMed ID: 30863499
[TBL] [Abstract][Full Text] [Related]
13. BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZ.
Lai D; Yang X
Cell Signal; 2013 Aug; 25(8):1720-8. PubMed ID: 23673366
[TBL] [Abstract][Full Text] [Related]
14. PIN1 facilitates ubiquitin-mediated degradation of serine/threonine kinase 3 and promotes melanoma development via TAZ activation.
Kim G; Bhattarai PY; Lim SC; Kim JY; Choi HS
Cancer Lett; 2021 Feb; 499():164-174. PubMed ID: 33253791
[TBL] [Abstract][Full Text] [Related]
15. [Role of Hippo-YAP/TAZ signaling pathway in mechanotransduction.].
Ishihara E; Nishina H
Clin Calcium; 2016; 26(12):1751-1756. PubMed ID: 27885187
[TBL] [Abstract][Full Text] [Related]
16. Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis.
Li YW; Shen H; Frangou C; Yang N; Guo J; Xu B; Bshara W; Shepherd L; Zhu Q; Wang J; Hu Q; Liu S; Morrison CD; Sun P; Zhang J
Cell Cycle; 2015; 14(1):146-56. PubMed ID: 25602524
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions.
Mei L; Yuan L; Shi W; Fan S; Tang C; Fan X; Yang W; Qian Y; Hussain M; Wu X
Cancer Lett; 2017 Feb; 386():1-11. PubMed ID: 27847303
[TBL] [Abstract][Full Text] [Related]
18. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins.
Nguyen HT; Kugler JM; Cohen SM
PLoS One; 2017; 12(1):e0169587. PubMed ID: 28061504
[TBL] [Abstract][Full Text] [Related]
19. Non-canonical Hippo signaling regulates immune responses.
Chen L
Adv Immunol; 2019; 144():87-119. PubMed ID: 31699221
[TBL] [Abstract][Full Text] [Related]
20. The Hippo pathway in biological control and cancer development.
Chan SW; Lim CJ; Chen L; Chong YF; Huang C; Song H; Hong W
J Cell Physiol; 2011 Apr; 226(4):928-39. PubMed ID: 20945341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
